Lexicon Pharmaceuticals
LXRX
#6315
Rank
C$1.28 B
Marketcap
C$2.89
Share price
5.91%
Change (1 day)
215.70%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): C-$0.27

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$0.27. In 2024 the company made an earnings per share (EPS) of C-$0.90 an increase over its 2023 EPS that were of C-$1.12.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.27-69.68%
2024C-$0.90-20%
2023C-$1.1231.15%
2022C-$0.86-0%
2021C-$0.8610.91%
2020C-$0.77-145.08%
2019C$1.71-206.09%
2018C-$1.61-5.74%
2017C-$1.71-10.95%
2016C-$1.922640%
2015C-$0.07008-96.34%
2014C-$1.91-2.53%
2013C-$1.96-9.09%
2012C-$2.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
C$25.54-9,689.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.75-3,010.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$59.61-22,484.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$8.56 3,115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$8.83-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.70 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C-$1.05 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$1.96-836.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C-$107.52 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA